Literature DB >> 11843818

Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.

R Bhatia1, H A Munthe, S J Forman.   

Abstract

Abnormal progenitor circulation and extramedullary haematopoiesis are characteristic features of chronic myelogenous leukaemia (CML). Growth factor (GF) and beta1-integrin interactions play an important role in regulation of progenitor trafficking to and from the marrow space. CML progenitors demonstrate abnormal beta1-integrin-mediated adhesion to fibronectin (FN). In the present study we investigated whether GF modulation of beta1-integrin-mediated adhesion and migration was altered in CML progenitors. Culture with low concentrations of GF enhanced normal progenitor adhesion to FN compared with no GF, but failed to enhance CML progenitor adhesion to FN. Similarly, high concentrations of selected GF rapidly enhanced beta1-integrin-mediated adhesion of normal progenitors to FN through a phosphotidylinositol-3 (PI-3) kinase-dependent mechanism, but failed to increase CML progenitor adhesion. Exposure to a BCR-ABL tyrosine kinase inhibitor restored GF modulation of CML progenitor adhesion. CML colony-forming cells (CFC) demonstrated increased migration across FN-coated transwells compared with normal CFC in the absence of GF. The addition of stem cell factor resulted in enhanced migration of CML and normal CFC on FN. In conclusion, GF stimulation failed to enhance integrin-mediated adhesion but enhanced migration in CML progenitors on FN. BCR-ABL induced abnormalities in GF-integrin interactions could contribute to abnormal circulation and microenvironmental localization of CML progenitors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843818     DOI: 10.1046/j.1365-2141.2001.03192.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

Review 1.  The evolution of the cancer niche during multistage carcinogenesis.

Authors:  Mary Helen Barcellos-Hoff; David Lyden; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2013-06-13       Impact factor: 69.800

2.  Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.

Authors:  Kran Suknuntha; Yuki Ishii; Lihong Tao; Kejin Hu; Brian E McIntosh; David Yang; Scott Swanson; Ron Stewart; Jean Y J Wang; James Thomson; Igor Slukvin
Journal:  Stem Cell Res       Date:  2015-10-31       Impact factor: 2.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.